4th Quarter - Report
BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC for BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Insurance INS
Opioid Addiction Crisis S.916- Protecting Patient Access to Emergency Medications Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BUCKLEY | — |
Health Issues HCR
Opioid Addiction Crisis S.916- Protecting Patient Access to Emergency Medications Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BUCKLEY | — |
Pharmacy PHA
Opioid Addiction Crisis S.916- Protecting Patient Access to Emergency Medications Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BUCKLEY | — |
Medicare/Medicaid MMM
Opioid Addiction Crisis S.916- Protecting Patient Access to Emergency Medications Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BUCKLEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.